Related Experiment Video
Updated: Jul 14, 2026
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
Immunotherapy with dendritic cells for prostate cancer.
Anna-Katharina Thomas-Kaskel1, Cornelius F Waller, Wolfgang Schultze-Seemann
1Department of Hematology and Oncology, University of Freiburg Medical Center, Hugstetterstrasse 55, Freiburg, Germany. anna-katharina.kaskel@uniklinik-freiburg.de
International Journal of Cancer
|May 22, 2007
Summary
Prostate cancer patients often experience PSA recurrence after surgery. Dendritic cell (DC) immunotherapy shows promise, inducing immune responses in many patients, but improvements are needed for durable clinical outcomes.
Area of Science:
- Immunology
- Oncology
- Cancer immunotherapy
Background:
- Radical prostatectomy for prostate cancer leads to PSA recurrence in up to 40% of patients.
- Biochemical relapse can progress to uncurable metastatic disease, necessitating alternative treatments.
- Dendritic cells (DCs) are potent antigen-presenting cells that can initiate anti-tumor immune responses.
Purpose of the Study:
- To evaluate the efficacy of dendritic cell (DC)-based immunotherapy for prostate cancer.
- To discuss treatment failure mechanisms and strategies for improving vaccination efficacy.
Main Methods:
- Review of studies involving dendritic cell (DC)-based immunotherapy in prostate cancer patients.
- Analysis of reported immune and clinical responses.
Main Results:
- Over 400 prostate cancer patients have received DC-based immunotherapy.
- Immune responses were observed in two-thirds of patients, with clinical responses in nearly half.
- Most clinical responses were modest and transient.
Conclusions:
- Dendritic cell (DC) immunotherapy has shown potential in treating prostate cancer, particularly in cases of recurrence or hormone-refractory disease.
- Further research is needed to understand treatment failures and enhance the efficacy of DC-based vaccination strategies for more durable patient benefits.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...